secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001654954-25-010776
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q3 revenue $2.0M (down 17% YoY); net loss narrows to $0.2M
--------------------------------------------------------------------------

- Revenue for three months ended July 31, 2025 was $2.0M, down from $2.4M in the same period last year.
- Net loss for Q3 was $0.2M, an improvement of $0.1M compared to a $0.3M loss in Q3 2024.
- Nine-month revenue was $6.9M vs $7.2M YoY; net loss $0.1M, improvement of $0.7M.
- CEO cites cost streamlining and preparation for imminent start of several significant projects.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425010776/0001654954-25-010776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425010776/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-010776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer